Executive Vice President
Taipei Medical University
Dr. Kang-Yun Lee is Professor of Internal medicine and Executive Vice President of Taipei Medical University (TMU). He headed the Asthma Assembly of Asian Pacific Society of Respirology (APSR) during 2020-2023. Dr. Lee qualified his first degree of Medicine at TMU and received a PhD in clinical pharmacology at Imperial College London in 2006.
Dr. Lee had been working on pathogenesis of asthma, COPD, and lung cancer. In addition to clinically orientated research, he has been working on molecular control of inflammation and immunity in lung diseases. He is interested in microenvironment and immune therapy for lung cancer. His lab identified a novel myeloid-derived suppressor cell (MDSC) in lung cancer, which has been implicated in tumor aggressiveness and drug resistance. Dr. Lee also participates in a great number of clinical trials, in variable lung diseases, including airways diseases, lung cancer and pneumonia.